GO Term | Evidence Code | PMID |
---|---|---|
post-embryonic development | ||
platelet-derived growth factor receptor signaling pathway | ||
androgen metabolic process | ||
negative regulation of gene expression | ||
response to 2,3,7,8-tetrachlorodibenzodioxine |
GO Term | Evidence Code | PMID |
---|---|---|
NAD+ ADP-ribosyltransferase activity | ||
cis-regulatory region sequence-specific DNA binding | ||
NAD+- protein-cysteine ADP-ribosyltransferase activity | ||
NAD+-protein ADP-ribosyltransferase activity | ||
metal ion binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:3772 | intraventricular meningioma | |
DOID:3829 | pituitary adenoma | |
DOID:4141 | intraorbital meningioma | |
DOID:4210 | clear cell meningioma | |
DOID:4362 | cervical cancer | |
DOID:4587 | benign meningioma | |
DOID:4588 | secretory meningioma | |
DOID:4594 | microcystic meningioma | |
DOID:4766 | embryoma | |
DOID:6114 | cerebral convexity meningioma |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
107086965 | CYPVA10016 | ||
103677562 | URSMA01595 | ||
114053128 | VOMUR06896 | ||
113893134 | BOBOX29077 | ||
102533974 | VICPA01064 | ||
100946531 | OTOGA08399 | ||
112149506 | ORYME06494 | ||
101080203 | TAKRU03471 | ||
102019653 | CHILA12297 | ||
108238188 | KRYMA13093 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024